StonvexLoading…
StonvexStonvexStonvexCore line items from RGLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $469.13M | $1.03B | $655.15M | $403.08M |
Operating Income | $297.09M | $638.17M | $427.30M | $264.95M |
Net Income | $281.13M | $466.28M | $372.67M | $245.85M |
EPS (Diluted) | $3.30 | $6.69 | $5.65 | $3.73 |
Total Assets | $9.49B | $9.54B | $4.47B | $3.57B |
Total Liabilities | $2.03B | $2.33B | $1.05B | $253.49M |
Cash & Equivalents | $234.14M | $233.72M | $172.85M | $248.18M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 84.79M | 84.50M | 65.76M | 65.76M |